DIA Europe 2019 has ended
Back To Schedule
Wednesday, February 6 • 12:00 - 13:15
#S0602: Incorporation and Acceptance of Real World Evidence in Market Access Discussions – Case Studies

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Component Type: Session

The session has the aim to cover important and challenging issues around the concept of RWD. Who needs what? What will different stakeholder be prepared to use and trust when RWD is on the table?


Niklas Hedberg, MPharm


Partnering to Enable Evidence Generation
David Myers

What Do We Do with New Data Sets?
Evert Jan van Lente, MS

How Do Patients Want to be Approached to Contribute to a Better Environment for RWD? Do Patients Experience A Double Role, Sharing Their Own Data and Depending on the Decisions Based on Those Data?
Bettina Ryll

avatar for Niklas Hedberg

Niklas Hedberg

Chair EUnetHTA Executive Board; Chief Pharmacist, Dental and Pharmaceutical Benefits Agency, TLV, Sweden
Niklas Hedberg is the Chief Pharmacist at the Swedish national governmental authority, the Dental and Pharmaceuticals Benefits Agency (TLV). He is the Chair of the EUnetHTA Executive Board and the TLV lead partner in EUnetHTA WP 3 Evaluation. Niklas has been working with pricing and... Read More →

Evert Jan van Lente

Director EU-Affairs, AOK Bundesverband (Federal Insurer)
Mr. van Lente is a health economist and director EU-Affairs of the AOK-Bundesverband, Germany. He is involved in developments in the health sector on European level, especially in pharmaceuticals, medical devices, e- and mHealth. He is based in Brussels and Berlin. The AOK-Group is... Read More →

David Myers

Associate Director Market Access RWE Partnerships, Janssen Pharmaceuticals
David is Associate Director Market Access and Real World Evidence Partnerships, working for Janssen Pharmaceuticals in Stockholm, Sweden. He works in Janssen's research partnership with Karolinska Institutet, as well as other strategic partnerships around the world. He holds a bachelor's... Read More →
avatar for Bettina Ryll

Bettina Ryll

Chair ESMO Patient Advocates Working Group (PAWG), Melanoma Patients
Bettina Ryll, MD/PhD founded the Melanoma Patient Network Europe in 2013 and developed a special interest in patient-centric clinical research and drug development. Bettina’s current areas of focus are Adaptive Licensing/ MAPPS , innovative sustainable healthcare models and patient-centered... Read More →

Wednesday February 6, 2019 12:00 - 13:15 CET
K1 Austria Center Vienna Bruno-Kreisky-Platz 1 1220 Vienna Austria
  06 Access to Medicines, Session
  • Featured Topics Value and Access
  • Tags Session